Related Experiment Video
Updated: Jan 30, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Oxalomalate reduces tumor progression in melanoma via ROS-dependent proapoptotic and antiangiogenic effects
Sung Hwan Kim1, In Sup Kil1, Oh-Shin Kwon1
1School of Life Sciences and Biotechnology, BK21 Plus KNU Creative BioResearch Group, College of Natural Sciences, Kyungpook National University, Taegu, South Korea.
Abstract:
The potent cytotoxicity of reactive oxygen species (ROS) can cause various diseases, however, it may also serve as a powerful chemotherapeutic strategy capable of killing cancer cells. Oxalomalate (OMA, α-hydroxy-β-oxalosuccinic acid), a tricarboxylic acid intermediate, is a well-known competitive inhibitor of two classes of NADP+-dependent isocitrate dehydrogenase (IDH) isoenzymes, which serve as the major antioxidants and redox regulators in the mitochondria and cytosol. In this study, we investigated the therapeutic effects of OMA in melanoma and elucidated the associated underlying mechanisms of action using in vitro and in vivo models. OMA targeting IDH enzymes suppressed melanoma growth through activation of apoptosis and inhibition of angiogenesis. Mechanistically, our findings showed that OMA activated p53-mediated apoptosis through ROS-dependent ATM-Chk2 signaling and reduced the expression of vascular endothelial growth factor through ROS-dependent E2F1-mediated hypoxia inducible factor-1α degradation. In particular, OMA-induced suppression of IDH activity resulted in induction of ROS stress response, ultimately leading to apoptotic cell death and antiangiogenic effects in melanoma cells. Thus, OMA might be a potential candidate drug for melanoma skin cancer therapy.
Insights
Oxalomalate (OMA) shows promise as a melanoma cancer therapy by inhibiting isocitrate dehydrogenase (IDH) enzymes. This leads to cancer cell death via apoptosis and reduced blood vessel growth, suggesting OMA as a potential drug candidate.
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Reactive oxygen species (ROS) exhibit potent cytotoxicity but can be harnessed for cancer therapy.
- Oxalomalate (OMA) is a tricarboxylic acid intermediate and a known inhibitor of NADP+-dependent isocitrate dehydrogenase (IDH) enzymes, crucial for cellular antioxidant defense and redox regulation.
Purpose of the Study:
- To investigate the therapeutic potential of OMA in melanoma.
- To elucidate the mechanisms underlying OMA's anti-melanoma effects.
Main Methods:
- In vitro and in vivo melanoma models were utilized.
- Investigated OMA's impact on IDH enzyme activity, apoptosis, angiogenesis, and key signaling pathways (p53, ATM-Chk2, E2F1, HIF-1α).
Main Results:
- OMA suppressed melanoma growth by activating apoptosis and inhibiting angiogenesis.
- OMA induced p53-mediated apoptosis via ROS-dependent ATM-Chk2 signaling.
- OMA reduced vascular endothelial growth factor expression through ROS-dependent E2F1-mediated degradation of hypoxia-inducible factor-1α.
- OMA-induced IDH inhibition led to ROS stress, resulting in apoptotic cell death and antiangiogenic effects.
Conclusions:
- OMA demonstrates therapeutic efficacy against melanoma by inducing oxidative stress and activating apoptotic pathways.
- OMA inhibits melanoma progression by suppressing angiogenesis through a ROS-dependent mechanism.
- OMA is a potential candidate for melanoma skin cancer therapy.
More Related Videos
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
07:12Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Published on: July 7, 2016
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Frequency-dependent Selection
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Drug Dependence